Contract Facilitation

The Office of Clinical Trials administration is responsible for the review, negotiation, and execution of all confidential disclosure agreements and clinical trial agreements for industry-initiated research conducted at VCH, either in an in-patient or out-patient setting.

Confidential Disclosure Agreement (CDA)

Submitting a CDA to the Office of Clinical Trials Administration for review:

  1. The CDA may be sent directly to the Principal Investigator or to the Office of Clinical Trials Administration. If the Principal Investigator receives a CDA, please forward it to Jason Sim for review.
  2. Once the terms of the CDA have been negotiated, the Office of Clinical Trials Administration will coordinate signatures.
  3. Once the Office of Clinical Trials Administration receives a fully executed CDA, a copy will be sent to the Principal Investigator for his/her files.

Clinical Trial Agreement (CTA)

Submitting the CTA to the Office of Clinical Trials Administration for review:

  1. Email an electronic copy of the CTA to Stephania Manusha as soon as the CTA is received.
  2. A “Sponsor Initiated Clinical Trial Information Form” is required for every new CTA and must be submitted to the Office of Clinical Trials Administration together with the electronic copy of the CTA. 
  3. Once the terms of the CTA have been negotiated, the Office of Clinical Trials Administration  will coordinate signatures.
  4. Once the Office of Clinical Trials Administration receives a fully executed CTA, a copy will be sent to the Principal Investigator for his/her files.